Monday, September 8, 2008

Clinical trial for autoimmune drug halts

Recently, the Birmingham Business Journal reported that a clinical trial for BioCryst Pharmaceuticals found that tested drug BCX-4208 was shelved due to the trial showing that it had no effect on psoriasis. The test included 66 patients who suffered from severe psoriasis.

The drug did prove to meet this objective:
The study showed the drug met another objective by suppressing the number of immune T-cells which act as gatekeepers for the body in determining whether to accept transplanted organ.

No comments:

Post a Comment